Latest Breaking News On - Anne marie dingemans - Page 1 : comparemela.com

First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study                 First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study Inivata’s InVisionFirst®-Lung is being used for ctDNA testing and monitoring of patients treated with lorlatinib Study supported by a grant from Pfizer Inc. Research Triangle Park, NC, USA and Cambridge, UK, 20 January 2021 – Inivata, a leader in liquid biopsy, today announces that the first patients have been tested using InVisionFirst®-Lung as part of the Phase II ALKALINE trial sponsored by the European Organisation for Research and Treatment of Cancer (EORTC). As part of the study Inivata’s InVisionFirst-Lung liquid biopsy will be used to test and monitor ALK positive non-small cell lung cancer (NSCLC) patients initiating treatment with lorlatinib, Pfizer Inc.’s third generation ALK inhibitor therapy.

United statesUnited kingdomComunidad autonoma de catalunaLaura mezquitaClive morrisInivata invisionfirstAnne marie dingemansKaren chandler smithUsinginivata invisionfirstTreatment of cancer european organisation for researchCancer research united kingdom cambridge instituteErasmus university medical centerEuropean organisation for researchUniversity of cambridgeDepartment of medical oncologyErasmus mc cancer institute